EPHA5 and lung cancer: EphA5 was found to be expressed in human lung cancers (∼70%), and the intensity of staining was substantially greater in SCC (median = 86.67) compared with ACC (median = 66.67) (Wilcoxon rank sum test, p = 0.0005) (Fig. 1E).